| Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors (NCT02406794) | University of Malaga | 2016-05-01 |
| To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration (NCT03011996) | HK inno.N Corporation | 2016-05-01 |
| Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies (NCT02961101) | Han weidong | 2016-05-01 |
| A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma (NCT02748135) | Oncurious NV | 2016-05-01 |
| A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution (NCT02751294) | GlaxoSmithKline | 2016-05-01 |
| Phase 1, Dose-Escalation Study of IGN002 in NHL Subjects (NCT02519270) | Spectrum Pharmaceuticals, Inc | 2016-05-01 |
| MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B (NCT02783833) | Medicines for Malaria Venture | 2016-05-01 |
| A Pharmacokinetic Study of [14C]-GDC-0810 After Single Oral Administration in Healthy Female Participants (NCT02802670) | Genentech, Inc. | 2016-05-01 |
| SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study (NCT02840708) | Niigata University Medical & Dental Hospital | 2016-05-01 |
| Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation (NCT02719574) | Forma Therapeutics, Inc. | 2016-04-30 |
| A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension (NCT02742649) | ForSight Vision5, Inc. | 2016-04-30 |
| A Study Comparing Amounts of Tafamidis (PF-06291826) in the Blood Without Food in Healthy Volunteers (NCT02746926) | Pfizer | 2016-04-29 |
| PF-06671008 Dose Escalation Study in Advanced Solid Tumors (NCT02659631) | Pfizer | 2016-04-28 |
| Safety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or Lymphomas (NCT02675439) | Chinook Therapeutics, Inc. (formerly Aduro) | 2016-04-28 |
| Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors (NCT02658214) | AstraZeneca | 2016-04-28 |
| TAK-020 Relative Bioavailability and Food Effect Study in Healthy Participants (NCT02723201) | Takeda | 2016-04-28 |
| Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation (NCT02669251) | National Cancer Institute (NCI) | 2016-04-28 |
| Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes (NCT02721875) | Boehringer Ingelheim | 2016-04-28 |
| Cefixime / Azithromycin pK Study (NCT02708992) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-04-28 |
| A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics (NCT02752516) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2016-04-27 |
| Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. (NCT02748902) | Neal D. Bhatia, MD | 2016-04-27 |
| A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects (NCT02742935) | Jiangsu HengRui Medicine Co., Ltd. | 2016-04-27 |
| Retention of Potassium From Potatoes and Potassium Gluconate, and the Effect on Blood Pressure. (NCT02697708) | Purdue University | 2016-04-27 |
| Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes (NCT02680795) | Acrotech Biopharma Inc. | 2016-04-27 |
| Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma (NCT02667886) | X4 Pharmaceuticals | 2016-04-27 |
| Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis (NCT02743871) | Pfizer | 2016-04-27 |
| Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease (NCT02678143) | Washington University School of Medicine | 2016-04-26 |
| Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone (NCT02806258) | University Hospital, Grenoble | 2016-04-26 |
| A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma (NCT02685826) | Celgene | 2016-04-25 |
| A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects (NCT02770404) | Wockhardt | 2016-04-25 |
| A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD) (NCT02754830) | Eli Lilly and Company | 2016-04-25 |
| PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC (NCT02544880) | Donald T. Weed, MD, FACS | 2016-04-25 |
| Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors (NCT02630251) | GlaxoSmithKline | 2016-04-25 |
| Incretin Action in Physiology and Diabetes (NCT02550548) | David D'Alessio, M.D. | 2016-04-21 |
| A Study of Acalabrutinib in Combination With Rituximab + (Bendamustine or Venetoclax) in Subjects With MCL (NCT02717624) | Acerta Pharma BV | 2016-04-20 |
| Universal Cancer Peptide-based Vaccination in Metastatic NSCLC (NCT02818426) | Centre Hospitalier Universitaire de Besancon | 2016-04-20 |
| Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma (NCT02728531) | Washington University School of Medicine | 2016-04-18 |
| Phase 1 Study to Determine the Effect of Lenvatinib (E7080) on the Pharmacokinetics of Midazolam in Subjects With Advanced Solid Tumors (NCT02686164) | Eisai Inc. | 2016-04-18 |
| A Study of Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants (NCT05288816) | Alexion Pharmaceuticals, Inc. | 2016-04-18 |
| Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of BMS-986189 in Healthy Subjects (NCT02739373) | Bristol-Myers Squibb | 2016-04-18 |
| A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607 (NCT02737007) | GlaxoSmithKline | 2016-04-18 |
| Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE) (NCT02845713) | University Hospitals Cleveland Medical Center | 2016-04-17 |
| A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet (NCT02759224) | Boryung Pharmaceutical Co., Ltd | 2016-04-15 |
| Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy (NCT02984813) | The New York Eye & Ear Infirmary | 2016-04-15 |
| A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers. (NCT02711345) | Novartis Pharmaceuticals | 2016-04-15 |
| Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies (NCT03366350) | Wuhan Sian Medical Technology Co., Ltd | 2016-04-15 |
| Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer (NCT02657889) | Tesaro, Inc. | 2016-04-15 |
| Facilitating MAT Acceptance & Implementation in Problem Solving & Felony Courts (NCT03229447) | National Development and Research Institutes, Inc. | 2016-04-15 |
| Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer (NCT02713529) | AmMax Bio, Inc. | 2016-04-14 |
| Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma (NCT02697344) | Mayo Clinic | 2016-04-14 |
| A Combined Cell Therapy Approach to the Treatment of Neuroblastoma (NCT02745756) | H. Lee Moffitt Cancer Center and Research Institute | 2016-04-14 |
| A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Female Subjects (NCT02788721) | Lakefront Biotherapeutics NV | 2016-04-14 |
| Nicotinic Agonist Effects on BMI and Neuronal Response (NCT02458313) | University of Colorado, Denver | 2016-04-14 |
| An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread (NCT02658890) | Bristol-Myers Squibb | 2016-04-14 |
| Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies (NCT02576496) | Mundipharma Research Limited | 2016-04-14 |
| Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment (NCT02696642) | Bayer | 2016-04-14 |
| Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic Function (NCT02604498) | Zhejiang Medicine Co., Ltd. | 2016-04-14 |
| A Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Very Low-dose Cytarabine in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation (NCT02957032) | Philogen S.p.A. | 2016-04-13 |
| A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 in Patients With Advanced Melanoma (NCT02738489) | Jiangsu HengRui Medicine Co., Ltd. | 2016-04-13 |
| Sympathetic and Vascular Function in Takotsubo Syndrome (NCT05768542) | Danderyd Hospital | 2016-04-12 |
| Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma (NCT02728349) | Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd | 2016-04-12 |
| A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients (NCT02691975) | Jiangsu HengRui Medicine Co., Ltd. | 2016-04-12 |
| Fecal Transplant for Hepatic Encephalopathy (NCT03439982) | University of Alberta | 2016-04-12 |
| SinuSurf vs. Saline Solution in Normal Subjects (NCT02728505) | Vanderbilt University Medical Center | 2016-04-12 |
| Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy (NCT02680184) | Regeneron Pharmaceuticals | 2016-04-12 |
| PEEP and V/Q Mismatch in Premature Infants (NCT03109613) | Children's Hospital of Philadelphia | 2016-04-11 |
| Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer (NCT02535338) | National Cancer Institute (NCI) | 2016-04-11 |
| Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors (NCT02688101) | Collaborative Medicinal Development Pty Limited | 2016-04-11 |
| Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial) (NCT02599922) | Beacon Therapeutics | 2016-04-11 |
| A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD) (NCT02749630) | Genentech, Inc. | 2016-04-11 |
| Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung (NCT02713828) | PrECOG, LLC. | 2016-04-10 |
| A Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of BITS7201A in Healthy Volunteers and Participants With Mild Atopic Asthma (NCT02748642) | Genentech, Inc. | 2016-04-07 |
| Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I (NCT02811939) | Yale University | 2016-04-07 |
| A Study to Evaluate the Pharmacokinetics of the CORT125134 Phase 2 Formulation in Healthy Male Subjects (NCT06094712) | Corcept Therapeutics | 2016-04-07 |
| Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Chinese Healthy Volunteers (NCT02781753) | Tianjin SinoBiotech Ltd. | 2016-04-07 |
| Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso (NCT02663700) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-04-07 |
| A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors (NCT02715531) | Hoffmann-La Roche | 2016-04-06 |
| Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137) (NCT02626000) | Amgen | 2016-04-06 |
| A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects (NCT02721589) | Jiangsu HengRui Medicine Co., Ltd. | 2016-04-06 |
| A Pharmacokinetic Interaction Study Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin in Healthy Participants (NCT02611518) | Janssen Research & Development, LLC | 2016-04-05 |
| Second Line Treatment of Knee Osteochondral Lesion With Treated Osteochondral Graft (NCT02430558) | TBF Genie Tissulaire | 2016-04-05 |
| Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas (NCT02192359) | City of Hope Medical Center | 2016-04-05 |
| Chemoradiotherapy in Elderly Patients With Oesophagus Cancer (NCT02735057) | Centre Hospitalier Universitaire de Besancon | 2016-04-04 |
| Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer (NCT02595866) | National Cancer Institute (NCI) | 2016-04-04 |
| Weekly BI 836880 in Patients With Advanced Solid Tumors (NCT02689505) | Boehringer Ingelheim | 2016-04-04 |
| Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies (NCT02504619) | Gamida Cell ltd | 2016-04-04 |
| Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis (NCT02767297) | Flatley Discovery Lab LLC | 2016-04-01 |
| Influence of Dietary Nitrate on Vascular Dysfunction and Inflammation (NCT02715635) | Queen Mary University of London | 2016-04-01 |
| Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection (NCT02591420) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-04-01 |
| A Study to Evaluate Safety and Tolerability of JNJ-61178104 in Healthy Participants (NCT02758392) | Janssen Research & Development, LLC | 2016-04-01 |
| Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess (NCT02334384) | Eastern Virginia Medical School | 2016-04-01 |
| IM Recombinant Ricin Toxin Vaccine (RVEc) - 3-Dose Primary Series With Boost (NCT02385825) | U.S. Army Medical Research and Development Command | 2016-04-01 |
| Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies (NCT02721043) | Nina Bhardwaj | 2016-04-01 |
| A Multiple Dose Study of the Safety, Tolerability and PK of CMX157 in Healthy Subjects (NCT02585440) | ContraVir Pharmaceuticals, Inc. | 2016-04-01 |
| A Study to Evaluate the Effect of ACP-196 on the Heart Rate-corrected QT Interval in Healthy Adult Participants (NCT04867980) | Acerta Pharma BV | 2016-04-01 |
| Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection (NCT02647983) | Sunnybrook Health Sciences Centre | 2016-04-01 |
| A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer (NCT02737787) | Memorial Sloan Kettering Cancer Center | 2016-04-01 |
| Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease (NCT01428154) | Amgen | 2016-04-01 |
| Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female Patients (NCT02331810) | Sanofi | 2016-04-01 |
| Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers (NCT02767128) | Rockwell Medical Technologies, Inc. | 2016-04-01 |